This is to inform that due to some circumstances beyond the organizer control, “2nd Edition of International Conference on Gastroenterology” (Gastro 2024) during October 21-23, 2024 at Baltimore, MD, USA has been postponed. The updated dates and venue will be displayed shortly.
Your registration can be transferred to the next edition, if you have already confirmed your participation at the event.
For further details, please contact us at gastroenterology@magnusconference.com or call + 1 (702) 988-2320.
Pancreatic diseases are disorders that affect the pancreas, a large organ located behind the stomach that produces digestive enzymes and hormones that regulate blood sugar. Pancreatic diseases can include pancreatic cancer, pancreatitis, cystic fibrosis, and diabetes. Pancreatic cancer is the most common and is the fourth leading cause of cancer death in the United States. Pancreatitis is an inflammation of the pancreas, which can be caused by gallstones, alcohol use, or certain medications. Cystic fibrosis is an inherited disorder that causes a buildup of thick, sticky mucus in the pancreas, leading to damage to the organ. Diabetes is a condition in which the pancreas does not produce enough insulin, the hormone that helps regulate blood sugar. Treatment for pancreatic diseases varies depending on the diagnosis and severity. Pancreatic cancer is often treated with surgery, chemotherapy, and radiation, while pancreatitis is treated with medications and lifestyle changes. Cystic fibrosis is treated with medications, physical therapy, and a specialized diet. Diabetes is typically managed with medications, regular blood sugar monitoring, and lifestyle changes such as healthy eating and regular physical activity. It is important to talk to your doctor if you have symptoms or risk factors for pancreatic diseases, such as a family history of pancreatic cancer or diabetes, or heavy alcohol use. Early diagnosis and treatment can help improve outcomes and reduce the risk of complications.
Title : Novel exosomal biomarkers for MASH
Aleksandra Leszczynska, University of California San Diego, United States
Title : Validation of GLAS (GP73+LG2m+Age+Sex) and ASAP (Age+Sex+AFP+PIVKA-II) algorithms for the management of liver fibrosis, cirrhosis and cancer
Philip M Hemken, Abbott Diagnostics Division R&D, United States
Title : Reverse multiple myeloma: First hepatic amyloidosis then multiple myeloma
Milaris M Sanchez Cordero, Mayaguez Medical Center, Puerto Rico
Title : Autophagy promotes the survival of adipose mesenchymal stem/stromal cells and enhances their therapeutic effects in cisplatin-induced liver injury via modulating TGF-1/Smad and PI3K/AKT signaling pathways
Eman Mohamad EL Nashar, King Khalid University, Saudi Arabia
Title : Epigastric Impedance measures gastric malfunction non-invasively. Time to revive it
John Andrew Sutton, Gastria Ltd, United Kingdom
Title : Digesting the connection: Exploring the psychological impact of gastroenterology issues on mental and emotional well being
Tracy E Hill, MGS Products LLC, United States